92 results
8-K
EX-99.1
QTNTQ
Quotient Ltd
12 Dec 22
Quotient Limited Announces Intent to Voluntary Delist
4:44pm
into the Company’s business as necessary to effectuate its recently announced change in business strategy.
Nasdaq notified the Company on August 9, 2022
8-K
EX-10.1
QTNTQ
Quotient Ltd
7 Dec 22
Entry into a Material Definitive Agreement
6:49pm
strategy of the Company in which the Company would suspend its activities focused on the commercialization of its transfusion diagnostics products and would
8-K
QTNTQ
Quotient Ltd
7 Dec 22
Entry into a Material Definitive Agreement
6:49pm
and inject liquidity into the Company’s business as necessary to effectuate its strategy shift.
Under the Transaction Support Agreement, the Company … of the Company has approved a change in strategy in which the Company would suspend its activities focused on the commercialization of its transfusion diagnostics
8-K
EX-99.1
o95 c3mci
9 Aug 22
Results of Operations and Financial Condition
7:30am
8-K
2fbmk n3jic265h7q8
27 Jul 22
Departure of Directors or Certain Officers
4:06pm
PRER14A
d53h8rswfza9mfdzdq3
26 Jul 22
Preliminary revised proxy
4:02pm
PRE 14A
6pnjnvj762g v0c94c
15 Jul 22
Preliminary proxy
4:30pm
424B5
nux6wje9 txf4
27 Jun 22
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.1
ijwtw m6frqv0t88
24 Jun 22
Results of Operations and Financial Condition
8:02am
424B5
c8vvgj3 ra826n
23 Jun 22
Prospectus supplement for primary offering
5:23pm
SD
EX-1.01
9f7zbbc1 4u
31 May 22
Conflict minerals disclosure
4:50pm
8-K
EX-99.1
h79fhu 2yt3
8 Feb 22
Results of Operations and Financial Condition
7:15am